Glaxo’s Ex-China Head Reilly to Return as Part of Bribery Probe

GlaxoSmithKline Plc (GSK)’s former China head, Mark Reilly, will return to the country soon to assist with a government investigation into allegations of bribery.

The company’s global audit team, security personnel and senior lawyers will also go to Shanghai, China’s Ministry of Public Security said in a statement dated yesterday. The ministry said it welcomes the actions and hopes the unit will resume production and operation as soon as possible.

Glaxo appointed Herve Gisserot yesterday to replace Reilly, who left China after four executives were detained last month. Chinese state media published details this week of allegations the company used cash and sexual favors to bribe doctors and health officials in the country.

China National Radio reported yesterday that police in the central city of Zhengzhou are holding 18 Glaxo employees and medical personnel. The report didn’t provide details about how and when the staff were detained.

To contact Bloomberg News staff for this story: Bonnie Cao in Shanghai at

To contact the editor responsible for this story: Andreea Papuc at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.